ArticleTherapeutic advances in endocrinology and metabolism2026

A phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of vosoritide in children with hypochondroplasia: CANOPY HCH-3 study design.

Andrew Dauber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.